<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Diagnamed Holdings Corp. — News on 6ix</title>
<link>https://6ix.com/company/diagnamed-holdings-corp</link>
<description>Latest news and press releases for Diagnamed Holdings Corp. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 10 Dec 2025 12:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/diagnamed-holdings-corp" rel="self" type="application/rss+xml" />
<item>
<title>DiagnaMed Enters Acquisition Agreement to Acquire Colchester East Natural Hydrogen Project in Nova Scotia</title>
<link>https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-enters-acquisition-agreement-acquire-120000902</link>
<guid isPermaLink="true">https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-enters-acquisition-agreement-acquire-120000902</guid>
<pubDate>Wed, 10 Dec 2025 12:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - December 10, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or the "Company") is pleased to announce that it has entered into an acquisition agreement (the "Acquisition Agreement") to acquire the Colchester East Natural Hydrogen Project in Nova Scotia, consisting of 30 licenses totaling 2,104 claims.This strategic acquisition positions DiagnaMed directly within Canada's most active and rapidly expanding natural hydrogen corridor—a...</description>
</item>
<item>
<title>DiagnaMed and QIMC Confirm Major Expansion of Hydrogen Zone by Over 11 Kilometers in Ontario's Temiscamingue Graben</title>
<link>https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-qimc-confirm-major-expansion-110000766</link>
<guid isPermaLink="true">https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-qimc-confirm-major-expansion-110000766</guid>
<pubDate>Mon, 27 Oct 2025 11:00:00 GMT</pubDate>
<description>454 Samples Analyzed - 55% Above 500 ppm, 19 Samples Over 2,000 ppm, and a High of 2,817 ppm Hydrogen (H2)Toronto, Ontario--(Newsfile Corp. - October 27, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or "DMED" or the "Company"), in partnership with Québec Innovative Materials Corp. (CSE: QIMC) (OTCQB: QIMCF) (FSE: 7FJ), is pleased to announce that new soil-gas survey results from the Ontario section of the Témiscamingue Graben have confirmed a major northward extension</description>
</item>
<item>
<title>DiagnaMed and QIMC Confirm Major Discovery of Widespread Natural Hydrogen System in Ontario's Temiscamingue Graben</title>
<link>https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-qimc-confirm-major-discovery-110000314</link>
<guid isPermaLink="true">https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-qimc-confirm-major-discovery-110000314</guid>
<pubDate>Tue, 14 Oct 2025 11:00:00 GMT</pubDate>
<description>209 of 456 Soil Samples Exceed 500 ppm Hydrogen (H2), Including Multiple Readings Over 2,000 ppm - A Major Step Toward Defining Ontario-Québec Natural Hydrogen CorridorToronto, Ontario--(Newsfile Corp. - October 14, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or the "Company") and Québec Innovative Materials Corp. (CSE: QIMC) (OTCQB: QIMCF) (FSE: 7FJ) ("QIMC") are pleased to announce a major natural hydrogen discovery within Ontario's Témiscamingue Graben. The first.</description>
</item>
<item>
<title>DiagnaMed Holdings Corp. and Quebec Innovative Materials Corp. Sign Memorandum of Understanding with Temiscamingue First Nation to Advance Natural Hydrogen Development Along the Ontario-Quebec Hydrogen Corridor</title>
<link>https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-holdings-corp-quebec-innovative-163000891</link>
<guid isPermaLink="true">https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-holdings-corp-quebec-innovative-163000891</guid>
<pubDate>Wed, 08 Oct 2025 16:30:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - October 8, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or "DMED" or the "Company") is pleased to announce that it has entered into a Memorandum of Understanding (MOU) with Quebec Innovative Materials Corp. (CSE: QIMC) ("QIMC") and the Témiscamingue First Nation ("TFN") to advance collaborative efforts in natural hydrogen development along the Ontario-Quebec hydrogen corridor in the Lake Témiscamingue region, located within TFN's...</description>
</item>
<item>
<title>DiagnaMed Strengthens Leadership Team and Confirms Completion of Extensive Hydrogen Soil Sampling Program in Ontario's Temiscamingue Graben</title>
<link>https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-strengthens-leadership-team-confirms-110000381</link>
<guid isPermaLink="true">https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-strengthens-leadership-team-confirms-110000381</guid>
<pubDate>Tue, 30 Sep 2025 11:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - September 30, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or "DMED" or the "Company") is pleased to announce the appointment of André Turmel as Executive Chairman and Pam Sangster as Strategic Advisor, further enhancing the Company's leadership bench as it prepares for the upcoming release of exploration results from its flagship program in Ontario's Témiscamingue Graben.The program, carried out in collaboration with Quebec...</description>
</item>
<item>
<title>DiagnaMed Congratulates QIMC on Quebec Drill Permit Approval and Announces Significant Progress on Ontario Clean Natural Hydrogen Soil Sampling Program</title>
<link>https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-congratulates-qimc-quebec-drill-113000945</link>
<guid isPermaLink="true">https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-congratulates-qimc-quebec-drill-113000945</guid>
<pubDate>Thu, 24 Jul 2025 11:30:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - July 24, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or the "Company") proudly congratulates Québec Innovative Materials Corp. (QIMC) on receiving approval of their drill permit from the Government of Quebec. This permit issuance follows rigorous due diligence by provincial authorities and represents a strong endorsement of the innovative clean natural hydrogen model and methodologies developed collaboratively by QIMC and the Insti</description>
</item>
<item>
<title>DiagnaMed Announces Issuance of Restricted Share Units and Stock Options to Directors, Officers, and Consultants</title>
<link>https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-announces-issuance-restricted-share-001600557</link>
<guid isPermaLink="true">https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-announces-issuance-restricted-share-001600557</guid>
<pubDate>Tue, 22 Jul 2025 00:16:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - July 21, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or the "Company") is pleased to announce that, in accordance with its equity incentive plan, it has issued a total of 3,000,000 restricted share units (RSUs) and 2,500,000 stock options to directors, officers, and consultants of the Company.The RSUs and options were granted as part of DiagnaMed's ongoing efforts to align the interests of its leadership and key ...</description>
</item>
<item>
<title>DiagnaMed Announces Chief Financial Officer Transition</title>
<link>https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-announces-chief-financial-officer-113000630</link>
<guid isPermaLink="true">https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-announces-chief-financial-officer-113000630</guid>
<pubDate>Wed, 16 Jul 2025 11:30:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - July 16, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or the "Company") announces that Jing Peng has stepped down as Chief Financial Officer of the Company, effective immediately. The Board of Directors has appointed Mr. Edward Low as Interim Chief Financial Officer.Mr. Low has extensive experience in corporate finance and accounting for public companies, including financial reporting, regulatory compliance, and strategic planning.</description>
</item>
<item>
<title>DiagnaMed Launches Ontario Hydrogen Exploration Campaign in Conjunction with QIMC and INRS; Strengthens Board</title>
<link>https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-launches-ontario-hydrogen-exploration-113000809</link>
<guid isPermaLink="true">https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-launches-ontario-hydrogen-exploration-113000809</guid>
<pubDate>Thu, 03 Jul 2025 11:30:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - July 3, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) ("DiagnaMed" or the "Company"), is pleased to announce it has signed an agreement with the Institut national de la recherche scientifique (INRS) to initiate a comprehensive hydrogen exploration campaign on its Ontario properties, in conjunction with Quebec Innovative Materials Corp. (CSE: QIMC) ("QIMC"). The exploration will be led by Dr. Marc Richer-Laflèche and will include collaboration with members of th</description>
</item>
<item>
<title>DiagnaMed Advances Ontario Natural Hydrogen & Helium Program with Strategic Geological Targeting in Timiskaming Graben</title>
<link>https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-advances-ontario-natural-hydrogen-113000595</link>
<guid isPermaLink="true">https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-advances-ontario-natural-hydrogen-113000595</guid>
<pubDate>Tue, 17 Jun 2025 11:30:00 GMT</pubDate>
<description>INRS Begins Data Review Ahead of Upcoming Soil Gas Sampling Program Toronto, Ontario--(Newsfile Corp. - June 17, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or the "Company"), a Canadian technology innovator specializing in advanced hydrogen extraction technologies, is pleased to announce the advancement of its program in Ontario's Timiskaming district. In preparation for the upcoming soil gas sampling campaign, DiagnaMed, in collaboration with the Institut National</description>
</item>
<item>
<title>DiagnaMed Appoints John Karagiannidis as President & CEO; Fabio Chianelli Transitions to Director Role Strengthening Strategic Partnership with QIMC to Accelerate Natural Hydrogen Development in Ontario</title>
<link>https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-appoints-john-karagiannidis-president-120000107</link>
<guid isPermaLink="true">https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-appoints-john-karagiannidis-president-120000107</guid>
<pubDate>Thu, 12 Jun 2025 12:00:00 GMT</pubDate>
<description>TORONTO, June 12, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("”DiagnaMed” or “DMED") (CSE: DMED) (OTCQB: DGNMF), a Canadian technology innovator specializing in advanced hydrogen extraction technologies, today announced the appointment of John Karagiannidis as President and Chief Executive Officer, succeeding Fabio Chianelli, who is stepping down from his executive positions but will remain actively involved as a member of the Board of Directors. Mr. Karagiannidis In his continued role a</description>
</item>
<item>
<title>DiagnaMed Expands Clean Hydrogen Energy Extraction Capabilities to Demonstrate Proof of Concept of Proprietary Technology</title>
<link>https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-expands-clean-hydrogen-energy-120000164</link>
<guid isPermaLink="true">https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-expands-clean-hydrogen-energy-120000164</guid>
<pubDate>Thu, 05 Jun 2025 12:00:00 GMT</pubDate>
<description>TORONTO, June 05, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a Canadian technology innovator specializing in advanced hydrogen extraction technologies, is pleased to announce its recent strategic acquisition in Ontario, serving as a critical proof of concept for the Company's proprietary hydrogen extraction technology, directly aligning with its commitment to clean hydrogen energy solutions. This acquisition strategically position</description>
</item>
<item>
<title>DiagnaMed Acquires Strategic Ontario Claims Adjacent to QIMC in Premier Temiscamingue Hydrogen District</title>
<link>https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-acquires-strategic-ontario-claims-120000386</link>
<guid isPermaLink="true">https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-acquires-strategic-ontario-claims-120000386</guid>
<pubDate>Thu, 29 May 2025 12:00:00 GMT</pubDate>
<description>TORONTO, May 29, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a Canadian technology innovator specializing in advanced hydrogen extraction technologies, is pleased to announce the strategic acquisition of claims located adjacent to Quebec Innovative Materials Corp. (“QIMC”) (CSE: QIMC) (OTCQB: QIMCF), comprising 91 unpatented, single-cell mineral claims, each cell approximately 20 hectares in size, totaling an area of 1820 hectares,</description>
</item>
<item>
<title>DiagnaMed Announces Closing of LIFE Offering</title>
<link>https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-announces-closing-life-offering-120000329</link>
<guid isPermaLink="true">https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-announces-closing-life-offering-120000329</guid>
<pubDate>Mon, 14 Apr 2025 12:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - April 14, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or the "Company"), a leading provider of cutting-edge technology solutions for the hydrogen and life sciences industries, is pleased to announce that it has closed its previously announced private placement by issuing 13,250,333 units of the Company at an issue price of $0.03 per ...</description>
</item>
<item>
<title>DiagnaMed Granted FDA Orphan Drug Designation for Molecular Hydrogen to Treat Amyotrophic Lateral Sclerosis</title>
<link>https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-granted-fda-orphan-drug-130000509</link>
<guid isPermaLink="true">https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-granted-fda-orphan-drug-130000509</guid>
<pubDate>Mon, 03 Mar 2025 13:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - March 3, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed", "DMED", or the "Company"), a leading provider of cutting-edge technology solutions for the hydrogen and life sciences industries, today announced in a significant advancement for rare disease research, the Company has been granted Orphan Drug Designation (ODD) for molecular hydrogen in the treatment of amyotrophic lateral sclerosis (ALS) by the U.S. Food and Drug Administration</description>
</item>
<item>
<title>DiagnaMed Announces LIFE Offering of up to $510,000</title>
<link>https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-announces-life-offering-510-220000591</link>
<guid isPermaLink="true">https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-announces-life-offering-510-220000591</guid>
<pubDate>Thu, 27 Feb 2025 22:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - February 27, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or the "Company"), a leading provider of cutting-edge technology solutions for the hydrogen and life sciences industries, is pleased to announce that it is arranging a private placement of a minimum of $350,000 and a maximum of $510,000 of units (each, a "Unit"), at a price of $0.03 per Unit; (the "Offering"). The Offering is being led by ...</description>
</item>
<item>
<title>DiagnaMed To Support Quebec's Hydrogen Ambitions Through its Collaboration with QIMC</title>
<link>https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-support-quebecs-hydrogen-ambitions-130000235</link>
<guid isPermaLink="true">https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-support-quebecs-hydrogen-ambitions-130000235</guid>
<pubDate>Thu, 27 Feb 2025 13:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - February 27, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed", "DMED", or the "Company"), a leading provider of cutting-edge technology solutions for the hydrogen and life sciences industries, is pleased to announce its support of Québec Innovative Materials Corp. (CSE: QIMC) (FSE: 7FJ) (OTCQB: QIMCF) ("QIMC") efforts to establish hydrogen as a primary energy source in Quebec, aligning with the Province's mandate to reduce emissions by</description>
</item>
<item>
<title>DiagnaMed Advances Hydrogen Energy Technology Innovation</title>
<link>https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-advances-hydrogen-energy-technology-130000384</link>
<guid isPermaLink="true">https://6ix.com/company/diagnamed-holdings-corp/news/diagnamed-advances-hydrogen-energy-technology-130000384</guid>
<pubDate>Wed, 19 Feb 2025 13:00:00 GMT</pubDate>
<description>TORONTO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed”, “DMED”, or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a leading provider of cutting-edge technology solutions for the hydrogen and life sciences industries, is pleased to announce significant progress in the commercialization of its proprietary electromagnetic heating technology for hydrogen production. Developed by Dr. Qingwang Yuan of the HOPE Group at Texas Tech University, this groundbreaking innovation enables</description>
</item>
</channel>
</rss>